Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Johns Hopkins radiologists have repurposed a deep learning algorithm designed to detect tuberculosis on chest x-rays to, instead, help identify COVID-19.
The European Union has certified AI software for reading mammograms, clearing the way for a South Korea-based AI vendor to sell another of its AI products across the European Economic Area.
Healthcare providers are still asking the Trump administration for help securing personal protective equipment (PPE) as they continue to care for COVID-19 patients.
As part of its $5 million pandemic response, Amazon is placing more than 8,000 of its Echo Dot devices across dozens of senior-living facilities in parts of California and Washington State.
It was late April when the CDC added impaired taste and/or smell to its list of COVID-19 symptoms. Thanks to AI and natural language processing (NLP), researchers at the Medical University of South Carolina had beaten the federal agency to the punch.
AI enthusiasts have varying aims and incentives for pushing the technology into healthcare, but many parrot a common set of justifications. Do any of these sound familiar?
Researchers have demonstrated a way to visually explore small-molecule inhibitors that, according to algorithmic suggestions, show potential for targeting COVID-19’s main proteins.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
